Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
RxSight, Inc. | Co-President and Chief Financial Officer | Common Stock | 30.4K | $1.51M | $49.45 | Oct 1, 2024 | Direct |
AEON Biopharma, Inc. | Director | Stock Option | 96.2K | Aug 31, 2024 | Direct | ||
RxSight, Inc. | Co-President and Chief Financial Officer | Stock option (right to buy) | 83.4K | Oct 1, 2024 | Direct | ||
AEON Biopharma, Inc. | Director | Class A Common Stock | 36K | Aug 31, 2024 | Direct | ||
LENZ Therapeutics, Inc. | Director | Stock Option (right to buy) | 27K | Mar 21, 2024 | Direct | ||
AEON Biopharma, Inc. | Director | Stock Option | 16.3K | Mar 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RXST | RxSight, Inc. | Oct 1, 2024 | 5 | -$487K | 4 | Oct 2, 2024 | Co-President and Chief Financial Officer |
AEON | AEON Biopharma, Inc. | Aug 31, 2024 | 2 | $0 | 4 | Sep 4, 2024 | Director |
RXST | RxSight, Inc. | Aug 7, 2024 | 1 | $0 | 4 | Aug 8, 2024 | Co-President and Chief Financial Officer |
RXST | RxSight, Inc. | Jul 15, 2024 | 3 | $71.6K | 4 | Jul 16, 2024 | Co-President and Chief Financial Officer |
RXST | RxSight, Inc. | Jul 1, 2024 | 6 | -$924K | 4 | Jul 2, 2024 | Chief Financial Officer |
RXST | RxSight, Inc. | May 1, 2024 | 4 | -$367K | 4 | May 2, 2024 | Chief Financial Officer |
RXST | RxSight, Inc. | Apr 1, 2024 | 6 | -$998K | 4 | Apr 2, 2024 | Chief Financial Officer |
LENZ | LENZ Therapeutics, Inc. | Mar 21, 2024 | 1 | $0 | 4 | Mar 25, 2024 | Director |
LENZ | LENZ Therapeutics, Inc. | Mar 21, 2024 | 0 | $0 | 3 | Mar 25, 2024 | Director |
AEON | AEON Biopharma, Inc. | Mar 19, 2024 | 1 | $0 | 4 | Mar 21, 2024 | Director |
RXST | RxSight, Inc. | Mar 4, 2024 | 1 | $0 | 4 | Mar 6, 2024 | Chief Financial Officer |
RXST | RxSight, Inc. | Mar 1, 2024 | 5 | -$408K | 4 | Mar 5, 2024 | Chief Financial Officer |
RXST | RxSight, Inc. | Feb 5, 2024 | 8 | -$779K | 4 | Feb 7, 2024 | Chief Financial Officer |
RXST | RxSight, Inc. | Jan 26, 2024 | 5 | -$998K | 4 | Jan 29, 2024 | Chief Financial Officer |
RXST | RxSight, Inc. | Jan 2, 2024 | 4 | -$236K | 4 | Jan 3, 2024 | Chief Financial Officer |
RXST | RxSight, Inc. | Dec 15, 2023 | 5 | -$1.26M | 4 | Dec 18, 2023 | Chief Financial Officer |
AEON | AEON Biopharma, Inc. | Aug 14, 2023 | 1 | $0 | 4 | Aug 16, 2023 | Director |
AEON | AEON Biopharma, Inc. | Jul 21, 2023 | 0 | $0 | 3 | Jul 24, 2023 | Director |
RXST | RxSight, Inc. | Mar 9, 2023 | 1 | $0 | 4 | Mar 10, 2023 | Chief Financial Officer |
RXST | RxSight, Inc. | Jul 31, 2021 | 1 | $0 | 4 | Aug 2, 2021 | Chief Financial Officer |
RXST | RxSight, Inc. | Jul 29, 2021 | 0 | $0 | 3 | Jul 29, 2021 | Chief Financial Officer |